Paper32216675
Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?.
Xiaoyu P and 3 others. Gut Microbes, 2020. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?. Papers, record 32216675. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32216675
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Physiological Phenomena | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Gastrointestinal Tract | Major topic |
| Immune Checkpoint Inhibitors | Major topic |
| Immunotherapy | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Bacteria | |
| Biomarkers | |
| Feces | |
| Humans | |
| Immunity | |
| Symbiosis |
Source PubMed
References113
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27911839 | Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27911839 | PubMed |
| 2 | 25846071 | Effects of Bifidobacterium supplementation on intestinal microbiota composition and the immune response in healthy infants. | World J Pediatr | 2016 | https://conductscience.org/library/papers/25846071 | PubMed |
| 3 | 29782924 | Emerging biomarkers for immune checkpoint inhibition in lung cancer. | Semin Cancer Biol | 2018 | https://conductscience.org/library/papers/29782924 | PubMed |
| 4 | 24566914 | Intestinal epithelial cells: regulators of barrier function and immune homeostasis. | Nat Rev Immunol | 2014 | https://conductscience.org/library/papers/24566914 | PubMed |
| 5 | 27892954 | A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. | Nat Med | 2017 | https://conductscience.org/library/papers/27892954 | PubMed |
| 6 | 29567829 | The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29567829 | PubMed |
| 7 | 31194939 | Daily Sampling Reveals Personalized Diet-Microbiome Associations in Humans. | Cell Host Microbe | 2019 | https://conductscience.org/library/papers/31194939 | PubMed |
| 8 | 21747801 | Environmental and gut bacteroidetes: the food connection. | Front Microbiol | 2011 | https://conductscience.org/library/papers/21747801 | PubMed |
| 9 | 18854238 | Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. | Cell Host Microbe | 2008 | https://conductscience.org/library/papers/18854238 | PubMed |
| 10 | 28167454 | Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients. | Eur J Cancer | 2017 | https://conductscience.org/library/papers/28167454 | PubMed |
| 11 | 27571978 | The microenvironment of injured murine gut elicits a local pro-restitutive microbiota. | Nat Microbiol | 2016 | https://conductscience.org/library/papers/27571978 | PubMed |
| 12 | 27446020 | Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut. | Front Microbiol | 2016 | https://conductscience.org/library/papers/27446020 | PubMed |
| 13 | 25841013 | Anoxic Conditions Promote Species-Specific Mutualism between Gut Microbes In Silico. | Appl Environ Microbiol | 2015 | https://conductscience.org/library/papers/25841013 | PubMed |
| 14 | 26749362 | Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer. | J Gastroenterol | 2016 | https://conductscience.org/library/papers/26749362 | PubMed |
| 15 | 31398337 | Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. | Cell | 2019 | https://conductscience.org/library/papers/31398337 | PubMed |
| 16 | 30684593 | Gut microbiome and cancer immunotherapy. | Cancer Lett | 2019 | https://conductscience.org/library/papers/30684593 | PubMed |
| 17 | 29042691 | Gastric cancer: The gastric microbiota - bacterial diversity and implications. | Nat Rev Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/29042691 | PubMed |
| 18 | 27231050 | Gut microbiota, metabolites and host immunity. | Nat Rev Immunol | 2016 | https://conductscience.org/library/papers/27231050 | PubMed |
| 19 | 29610286 | Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29610286 | PubMed |
| 20 | 30121899 | Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism. | Cancer Immunol Immunother | 2018 | https://conductscience.org/library/papers/30121899 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42490947 | Microbiome and cancer: mechanistic insights, diagnostic potential, and therapeutic strategies. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42490947 | PubMed |
| 41564102 | Fecal microbiota transplantation ameliorates radiation-induced lung injury by reshaping gut metabolic homeostasis to activate FAM134B-mediated ER-phagy. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41564102 | PubMed |
| 41007735 | The Gut-Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007735 | PubMed |
| 40487934 | Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, and feces in hepatocellular carcinoma. | World J Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/40487934 | PubMed |
| 40333213 | Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40333213 | PubMed |
| 40116116 | Advances in research on the intestinal microbiota in the mechanism and prevention of colorectal cancer (Review). | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40116116 | PubMed |
| 34485534 | The Role of Gut Microbiota in Tumor Immunotherapy. | J Immunol Res | 2021 | https://conductscience.org/library/papers/34485534 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32216675
GET https://conductscience.org/api/papers/v1/32216675/references?page=2